Observations placeholder
Camptosar
Identifier
018163
Type of Spiritual Experience
Background
A description of the experience
Irinotecan (Camptosar, Campto,) is a drug used for the treatment of cancer.
Its main use is in colon cancer, in particular, in combination with other chemotherapy agents. Irinotecan received accelerated approval by the U.S. Food and Drug Administration (FDA) in 1996 and full approval in 1998.
On Dec, 09, 2016 6,277 people reported to have side effects when taking Camptosar.
Among them, 7 people (0.11%) have Hallucination
Time on Camptosar when people have Hallucinations :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucinations0.00%100.00%0.00%0.00%0.00%0.00%0.00%
On Oct, 3, 2015: 5,728 people reported to have side effects when taking Camptosar. Among them, 239 people (4.17%) have Death.
Time on Camptosar when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death80.56%13.89%2.78%2.78%0.00%0.00%0.00%